[RGLS] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
02-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -193.48%
YoY- -46.39%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 18 204 483 489 10,860 1,865 3,834 -97.15%
PBT -20,015 -19,515 -21,098 -21,212 -7,222 -13,016 -21,037 -3.25%
Tax 5 4 -8 -5 4 -16 -2 -
NP -20,020 -19,519 -21,090 -21,207 -7,226 -13,000 -21,035 -3.22%
Tax Rate - - - - - - - -
Total Cost 20,038 19,723 21,573 21,696 18,086 14,865 24,869 -13.35%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -111,222.22 -9,568.14 -4,366.46 -4,336.81 -66.54 -697.05 -548.64 3295.82%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -45.39 -44.33 -47.95 -48.28 -16.52 -30.01 -49.42 -5.48%
EPS Diluted -45.39 -44.33 -47.95 -48.28 -16.52 -30.01 -49.42 -5.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.